Estimated reading time: 4 minutes
Medically reviewed and verified by Kate Burke, MD, MHA
Some medical terminology can lose people immediately. If you are researching a condition and come across a phrase that seems important but is complicated, you might choose to skip right past it! For a disease like amyloidosis, that may be the term "biomarkers." Biomarkers are indicators of biological processes, conditions, or diseases. They can be found in your blood, body fluids, or tissues and provide valuable insights into your health. Essentially, biomarkers are like clues or signals that help doctors understand what is happening inside your body. They can indicate normal bodily functions, the presence of disease, or how well your body is responding to treatments. Here is a guide from PatientsLikeMe on what you need to know!
What are Biomarkers?
Biomarkers come in several types, each with a different purpose.
- Diagnostic Biomarkers: These help doctors identify a specific condition or disease.
- Monitoring Biomarkers: These are used to track the progression or improvement of a condition over time.
- Predictive Biomarkers: These suggest how well you might respond to a particular treatment.
- Susceptibility or Risk Biomarkers: These indicate the likelihood of developing a condition before it manifests.
- Prognostic Biomarkers: These provide information about the likely progression and outcome of a disease.
How Biomarkers Work in Amyloidosis
Diagnostic Biomarkers
For diagnosing amyloidosis, biomarkers help confirm the presence of the disease and its type.
- Free Light Chains: In AL amyloidosis, doctors measure the levels of free light chains (FLCs) in the blood. Abnormal levels indicate the presence of amyloidosis.
- Transthyretin (TTR): In ATTR amyloidosis, TTR levels in the blood are measured. Lower levels can suggest ATTR amyloidosis and help differentiate between its types.
Monitoring Biomarkers
Once doctors confirm a diagnosis, monitoring biomarkers helps track how the disease progresses or responds to treatment.
- Natriuretic Peptides (NPs): These are proteins in the blood that increase when the heart is stressed. High levels of NPs can indicate worsening cardiac involvement in both AL and ATTR amyloidosis.
- Troponins: These are proteins that rise when heart muscle damage occurs. Elevated troponin levels can mean cardiac damage because of amyloidosis.
Predictive Biomarkers
Predictive biomarkers help forecast how well a patient might respond to a specific treatment.
- Transthyretin Levels: In ATTR amyloidosis, changes in TTR levels after starting treatment can predict how well the treatment is working.
Prognostic Biomarkers
Prognostic biomarkers give an outlook on the likely course and outcome of the disease.
- Free Light Chain Ratio: In AL amyloidosis, the ratio of involved to uninvolved free light chains helps predict how the disease will progress and how well the treatment is working.
Why Biomarkers Are Important in Amyloidosis
Biomarkers are vital for several reasons. They help detect amyloidosis early, which is crucial for effective treatment and management. They also guide doctors in choosing the most appropriate treatments and adjusting them based on how well the patient is responding. Finally, biomarkers help evaluate the risk of disease progression and outcomes, enabling more personalized care.
Biomarkers are powerful tools. They help in diagnosing, monitoring, predicting treatment responses, and understanding the overall outlook of a disease. By using biomarkers, doctors can tailor treatments more effectively and improve outcomes! If you have amyloidosis or are at risk, understanding these biomarkers can help you work with your healthcare team to manage your condition better.
Nearly 1 million people have joined PatientsLikeMe. You can track your health, monitor the efficacy of treatment, and talk to people experiencing the same thing as you. Creating an account is free! Join today.